INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

CRCrane Co

CIK 0001944013

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells1 / 4
Max Insider Score37
Connections16with evidence

CR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
35
Kevin HernRJoint
CRCrane Co
Sale
SELL$50K – $100KAug 31, 2026Sep 25, 2026
traded Aug 31, 2026
+25dHOUSE PTR

Evidence

Verified connections

  • ← Disclosed trade inevidence
    Kevin HernSale disclosed 2026-09-25 · Sep 25, 2026
  • ← Insider ofevidence
    Haime Ellen McclainDirector · Apr 29, 2026
  • ← Insider ofevidence
    Tullis James L LDirector · Apr 29, 2026
  • ← Insider ofevidence
    Mcclure Charles GDirector · Apr 29, 2026
29
TL
Tullis James L LDirector
CRCrane Co
Open-market sale
SELL
$82K
400 sh
Aug 31, 2026
Sep 2, 2026
traded Aug 31, 2026
+2d
SEC FORM 4

Evidence

28
TL
Tullis James L LDirector
CRCrane Co
Open-market sale
SELL$138K
614 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC FORM 4

Evidence

9
TL
Tullis James L LDirector
CRCrane Co
Option exercise
M—
1,226 sh
Jun 1, 2026Jun 1, 2026
traded Jun 1, 2026
+0dSEC FORM 4

Evidence

17
TL
Tullis James L LDirector
CRCrane Co
Option exercise
M—
1,226 sh
Jun 1, 2026Jun 1, 2026
traded Jun 1, 2026
+0dSEC FORM 4

Evidence

37
LD
Lynch Susan DDirector
CRCrane Co
Open-market purchase
BUY$27K
150 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC FORM 4

Evidence

13
BR
Benante Martin RDirector
CRCrane Co
Grant or award
A—
1,004 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

9
MG
Mcclure Charles GDirector
CRCrane Co
Grant or award
A—
874 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

9
HM
Haime Ellen McclainDirector
CRCrane Co
Grant or award
A—
978 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

5
PJ
Pollino JenniferDirector
CRCrane Co
Grant or award
A—
874 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

9
LC
Lindsay Ronald CarterDirector
CRCrane Co
Grant or award
A—
874 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

17
LD
Lynch Susan DDirector
CRCrane Co
Grant or award
A—
874 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

9
TL
Tullis James L LDirector
CRCrane Co
Grant or award
A—
874 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

9
BR
Benante Martin RDirector
CRCrane Co
Grant or award
A—
49 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

13
KS
Kapoor SanjayDirector
CRCrane Co
Grant or award
A—
1,393 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

21
PV
Papanikolaou Marijane V.V.P., Controller & CAO
CRCrane Co
Option exercise
M—
508 sh
Apr 24, 2026Apr 28, 2026
traded Apr 24, 2026
+4dSEC FORM 4

Evidence

17
PV
Papanikolaou Marijane V.V.P., Controller & CAO
CRCrane Co
Tax withholding
F$43K
236 sh
Apr 24, 2026Apr 28, 2026
traded Apr 24, 2026
+4dSEC FORM 4

Evidence

21
PV
Papanikolaou Marijane V.V.P., Controller & CAO
CRCrane Co
Option exercise
M—
508 sh
Apr 24, 2026Apr 28, 2026
traded Apr 24, 2026
+4dSEC FORM 4

Evidence

9
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Option exercise
M—
162 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

5
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Option exercise
M—
162 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

5
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Tax withholding
F$16K
83 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

35
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Open-market sale
SELL$544K
2,693 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

18
MA
Maue Richard AExec. V.P & CFO
CRCrane Co
Tax withholding
F$61K
302 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

15
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Option exercise
M—
501 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

19
PV
Papanikolaou Marijane V.V.P., Controller & CAO
CRCrane Co
Tax withholding
F$9,429
47 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

19
AA
Alcala AlejandroExec. V.P. & Chief Op. Officer
CRCrane Co
Option exercise
M—
501 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

19
DM
D'Iorio Anthony M.Exec. V.P., Gen. Couns. & Sec.
CRCrane Co
Option exercise
M—
451 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

19
PV
Papanikolaou Marijane V.V.P., Controller & CAO
CRCrane Co
Option exercise
M—
100 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

20
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Option exercise
M$138K
2,693 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

18
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Tax withholding
F$51K
256 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

15
MH
Mitchell Max HDirector, Chairman, President and CEO
CRCrane Co
Option exercise
M—
2,260 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

15
PS
Polmanteer Tamara S.Exec. Vice President & CHRO
CRCrane Co
Option exercise
M—
301 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

23
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Option exercise
M—
501 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

19
PV
Papanikolaou Marijane V.V.P., Controller & CAO
CRCrane Co
Option exercise
M—
100 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

19
PS
Polmanteer Tamara S.Exec. Vice President & CHRO
CRCrane Co
Option exercise
M—
301 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

11
MH
Mitchell Max HDirector, Chairman, President and CEO
CRCrane Co
Option exercise
M—
2,260 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

19
MA
Maue Richard AExec. V.P & CFO
CRCrane Co
Option exercise
M—
651 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

15
PS
Polmanteer Tamara S.Exec. Vice President & CHRO
CRCrane Co
Tax withholding
F$28K
140 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

15
AA
Alcala AlejandroExec. V.P. & Chief Op. Officer
CRCrane Co
Option exercise
M—
501 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

15
DM
D'Iorio Anthony M.Exec. V.P., Gen. Couns. & Sec.
CRCrane Co
Tax withholding
F$46K
231 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

15
AA
Alcala AlejandroExec. V.P. & Chief Op. Officer
CRCrane Co
Tax withholding
F$40K
198 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

15
MA
Maue Richard AExec. V.P & CFO
CRCrane Co
Option exercise
M—
651 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

15
DM
D'Iorio Anthony M.Exec. V.P., Gen. Couns. & Sec.
CRCrane Co
Option exercise
M—
451 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

14
MH
Mitchell Max HDirector, Chairman, President and CEO
CRCrane Co
Tax withholding
F$210K
1,048 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

9
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Option exercise
M—
2,693 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

9
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Tax withholding
F$9,200
46 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

9
MA
Maue Richard AExec. V.P & CFO
CRCrane Co
Option exercise
M—
486 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

9
MA
Maue Richard AExec. V.P & CFO
CRCrane Co
Tax withholding
F$45K
226 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

8
MH
Mitchell Max HDirector, Chairman, President and CEO
CRCrane Co
Tax withholding
F$167K
835 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

9
DM
D'Iorio Anthony M.Exec. V.P., Gen. Couns. & Sec.
CRCrane Co
Tax withholding
F$35K
175 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

9
AA
Alcala AlejandroExec. V.P. & Chief Op. Officer
CRCrane Co
Tax withholding
F$34K
170 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

13
DM
D'Iorio Anthony M.Exec. V.P., Gen. Couns. & Sec.
CRCrane Co
Option exercise
M—
342 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

9
AA
Alcala AlejandroExec. V.P. & Chief Op. Officer
CRCrane Co
Option exercise
M—
432 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

9
PS
Polmanteer Tamara S.Exec. Vice President & CHRO
CRCrane Co
Tax withholding
F$22K
109 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

13
PV
Papanikolaou Marijane V.V.P., Controller & CAO
CRCrane Co
Tax withholding
F$6,800
34 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

9
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Option exercise
M—
90 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

13
PV
Papanikolaou Marijane V.V.P., Controller & CAO
CRCrane Co
Option exercise
M—
72 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

13
AA
Alcala AlejandroExec. V.P. & Chief Op. Officer
CRCrane Co
Option exercise
M—
432 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

13
MA
Maue Richard AExec. V.P & CFO
CRCrane Co
Option exercise
M—
486 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

5
MH
Mitchell Max HDirector, Chairman, President and CEO
CRCrane Co
Option exercise
M—
1,801 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

← Insider ofevidence
Lindsay Ronald Carter
Director · Apr 29, 2026
  • ← Insider ofevidence
    Papanikolaou Marijane V.V.P., Controller & CAO · Feb 11, 2026
  • ← Insider ofevidence
    Feldman Jason D.SVP, IR, Treasury & Tax · Feb 10, 2026
  • ← Insider ofevidence
    Kapoor SanjayDirector · Feb 2, 2026
  • ← Insider ofevidence
    Pollino JenniferDirector · Feb 2, 2026
  • ← Insider ofevidence
    Lynch Susan DDirector · Feb 2, 2026
  • ← Insider ofevidence
    D'Iorio Anthony M.Exec. V.P., Gen. Couns. & Sec. · Jan 28, 2026
  • ← Insider ofevidence
    Mitchell Max HDirector, Chairman, President and CEO · Jan 28, 2026
  • ← Insider ofevidence
    Benante Martin RDirector · Jan 28, 2026
  • ← Insider ofevidence
    Maue Richard AExec. V.P & CFO · Jan 28, 2026
  • ← Insider ofevidence
    Alcala AlejandroExec. V.P. & Chief Op. Officer · Jan 28, 2026
  • ← Insider ofevidence
    Polmanteer Tamara S.Exec. Vice President & CHRO · Jan 28, 2026